Mark W. SLEEMAN

Person

Mahopac, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Genetically modified mouse with a humanized PNPLA3 gene and methods...
- Patent number 12,250,931
- Issue date Mar 18, 2025
- REGENERON PHARMACEUTICALS, INC.
- Xiping Cheng
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Human antibodies to human angiopoietin-like protein 4
- Patent number 9,120,851
- Issue date Sep 1, 2015
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity human antibodies to PCSK9
- Patent number 8,501,184
- Issue date Aug 6, 2013
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating hypercholesterolemia using antibodies to PCSK9
- Patent number 8,357,371
- Issue date Jan 22, 2013
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies to human angiopoietin-like protein 4
- Patent number 8,354,103
- Issue date Jan 15, 2013
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High affinity human antibodies to PCSK9
- Patent number 8,062,640
- Issue date Nov 22, 2011
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating type I diabetes by blocking VEGF-mediated activity
- Patent number 7,378,095
- Issue date May 27, 2008
- REGENERON PHARMACEUTICALS, INC.
- Jingtai Cao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating diabetes by blocking VEGF-mediated activity
- Patent number 7,052,691
- Issue date May 30, 2006
- REGENERON PHARMACEUTICALS, INC.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified ciliary neurotrophic factor, method of making and methods...
- Patent number 6,680,291
- Issue date Jan 20, 2004
- REGENERON PHARMACEUTICALS, INC.
- Stanley J. Wiegand
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PEPTIDE ACIDS AS A GLP1R AGONIST AND ANTIBODY-DRUG CONJUGATES THEREOF
- Publication number 20250171516
- Publication date May 29, 2025
- Regeneron Pharmaceuticals, Inc.
- Amy HAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF
- Publication number 20250136675
- Publication date May 1, 2025
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Of Liver Disease Or Metabolic Disorder With Folliculin In...
- Publication number 20250129366
- Publication date Apr 24, 2025
- Regeneron Pharmaceuticals, Inc.
- Luca Andrea Lotta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Muscle Disorder With Folliculin Interacting Protein 1...
- Publication number 20250075216
- Publication date Mar 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Luca Andrea Lotta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION
- Publication number 20240199728
- Publication date Jun 20, 2024
- Regeneron Pharmaceuticals, Inc.
- Sandra KLEINER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-HUMAN ANIMALS COMPRISING A HUMANIZED PNPLA3 LOCUS AND METHODS O...
- Publication number 20210227812
- Publication date Jul 29, 2021
- Regeneron Pharmaceuticals, Inc.
- Xiping Cheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
- Publication number 20130266574
- Publication date Oct 10, 2013
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods for Treating Hypercholesterolemia Using Antibodies to PCSK9
- Publication number 20110256148
- Publication date Oct 20, 2011
- Regeneron Pharmaceuticals, Inc.
- MARK W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4
- Publication number 20110159015
- Publication date Jun 30, 2011
- Regeneron Pharmaceuticals, Inc.
- Mark W. SLEEMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9
- Publication number 20110065902
- Publication date Mar 17, 2011
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
High Affinity Human Antibodies to PCSK9
- Publication number 20100166768
- Publication date Jul 1, 2010
- Regeneron Pharmaceuticals, Inc.
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating obesity with combination therapeutics
- Publication number 20060058224
- Publication date Mar 16, 2006
- George D. Yancopoulos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating type I diabetes by blocking VEGF-mediated activity
- Publication number 20060024309
- Publication date Feb 2, 2006
- Jingtai Cao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OGH fusion polypeptides and therapeutic uses thereof
- Publication number 20050250185
- Publication date Nov 10, 2005
- Andrew J. Murphy
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Methods for treating obesity and related conditions with glycoprote...
- Publication number 20050096264
- Publication date May 5, 2005
- Lynn MacDonald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating diabetes by blocking VEGF-mediated activity
- Publication number 20040213787
- Publication date Oct 28, 2004
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Transgenic SHIP2 animals and in vivo screening methods
- Publication number 20040205831
- Publication date Oct 14, 2004
- Mark W. Sleeman
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Method of treating liver steatosis in a mammal
- Publication number 20040142868
- Publication date Jul 22, 2004
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Therapeutic method for combined use of modified CNTF and thiadolidi...
- Publication number 20040033954
- Publication date Feb 19, 2004
- Mark W. Sleeman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark W. SLEEMAN

Person

Patents Grantslast 30 patents

Genetically modified mouse with a humanized PNPLA3 gene and methods...

Human antibodies to human angiopoietin-like protein 4

High affinity human antibodies to PCSK9

Methods for treating hypercholesterolemia using antibodies to PCSK9

Human antibodies to human angiopoietin-like protein 4

High affinity human antibodies to PCSK9

Methods of treating type I diabetes by blocking VEGF-mediated activity

Methods of treating diabetes by blocking VEGF-mediated activity

Modified ciliary neurotrophic factor, method of making and methods...

Patents Applicationslast 30 patents

PEPTIDE ACIDS AS A GLP1R AGONIST AND ANTIBODY-DRUG CONJUGATES THEREOF

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

Treatment Of Liver Disease Or Metabolic Disorder With Folliculin In...

Treatment Of Muscle Disorder With Folliculin Interacting Protein 1...

METHODS OF TREATING OBESITY, DIABETES, AND LIVER DYSFUNCTION

NON-HUMAN ANIMALS COMPRISING A HUMANIZED PNPLA3 LOCUS AND METHODS O...

HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4

Methods for Treating Hypercholesterolemia Using Antibodies to PCSK9

HUMAN ANTIBODIES TO HUMAN ANGIOPOIETIN-LIKE PROTEIN 4

HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9

High Affinity Human Antibodies to PCSK9

Methods of treating obesity with combination therapeutics

Methods of treating type I diabetes by blocking VEGF-mediated activity

OGH fusion polypeptides and therapeutic uses thereof

Methods for treating obesity and related conditions with glycoprote...

Methods of treating diabetes by blocking VEGF-mediated activity

Transgenic SHIP2 animals and in vivo screening methods

Method of treating liver steatosis in a mammal

Therapeutic method for combined use of modified CNTF and thiadolidi...